Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability. HIF-1 alpha is the oxygen-regulated subunit of HIF-1, an alpha beta heterodimeric complex. HIF-1 alpha is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degradation by the ubiquitination complex pVHL, the protein of the von Hippel Lindau (VHL) tumour suppressor gene and a component of an E3 ubiquitin ligase complex. Capture of HIF-1 alpha by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1 alpha. The crystal structure of a hydroxylated HIF-1 alpha peptide bound to VCB (pVHL, elongins C and B) and solution binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL. Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues. This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normoxia, PHDs hydroxylate conserved proline residues within HIF-α subunits, increasing their affinity for the von Hippel–Lindau (pVHL) E3 ubiquitin ligase complex, which promotes polyubiquitination and 26S proteasomal degradation”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [44]
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [18]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 1×
“Cycles of rebuilding and refinement were carried out using the programs”
MethodHershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationAQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Research works printed but not linked: 1
- Hubbard, S. J. & Thornton, J. M. ‘NACCESS’, Computer Program Version 2.1.1 (Department of Biochemistry and Molecular Biology, Univ. Coll. London, London, 1996)
Cited by
Items 101–200 of 770
Frost, J., Galdeano, C., Soares, P., Gadd, M. S., Grzes, K. M., Ellis, L., Epemolu, O., Shimamura, S., Bantscheff, M., Grandi, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms13312 · Cited by 239
Kong, T., Eltzschig, H. K., Karhausen, J., Colgan, S. P., & Shelley, C. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401339101 · Cited by 242
Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation
Chu, T.-T., Gao, N., Li, Q.-Q., Chen, P.-G., Yang, X.-F., Chen, Y.-X., Zhao, Y.-F., & Li, Y.-M. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.02.016 · Cited by 247
Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases
Chowdhury, R., McDonough, M. A., Mecinović, J., Loenarz, C., Flashman, E., Hewitson, K. S., Domene, C., & Schofield, C. J. (2009) · Structure · doi:10.1016/j.str.2009.06.002 · Cited by 239
“Overview of Key Components of the HIF Signaling System Showing the Role of PHD Catalyzed Prolyl-4-Hydroxylation The ability of VCB (pVHL, elongins B and C) to discriminate between hydroxylated and nonhydroxylated HIFα is central to the hypoxic response, with the difference in KD for hydroxylated versus non-hydroxylate…”
BackgroundSelf-citationElks, P. M., van Eeden, F. J., Dixon, G., Wang, X., Reyes-Aldasoro, C. C., Ingham, P. W., Whyte, M. K. B., Walmsley, S. R., & Renshaw, S. A. (2011) · Blood · doi:10.1182/blood-2010-12-324186 · Cited by 239
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
Yeh, T.-L., Leissing, T. M., Abboud, M. I., Thinnes, C. C., Atasoylu, O., Holt-Martyn, J. P., Zhang, D., Tumber, A., Lippl, K., Lohans, C. T., et al. (2017) · Chem. Sci. · doi:10.1039/c7sc02103h · Cited by 232
Self-citationKuznetsova, A. V., Meller, J., Schnell, P. O., Nash, J. A., Ignacak, M. L., Sanchez, Y., Conaway, J. W., Conaway, R. C., & Czyzyk-Krzeska, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436037100 · Cited by 232
Hypoxia-Inducible Factor as an Angiogenic Master Switch
Hashimoto, T., & Shibasaki, F. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00033 · Cited by 231
Hypoxic Culture Conditions as a Solution for Mesenchymal Stem Cell Based Regenerative Therapy
Haque, N., Rahman, M. T., Abu Kasim, N. H., & Alabsi, A. M. (2013) · The Scientific World Journal · doi:10.1155/2013/632972 · Cited by 230
PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery
Gu, S., Cui, D., Chen, X., Xiong, X., & Zhao, Y. (2018) · BioEssays · doi:10.1002/bies.201700247 · Cited by 231
Optical Control of Small Molecule-Induced Protein Degradation
Naro, Y., Darrah, K., & Deiters, A. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b12718 · Cited by 218
Mechanism of CRL4Cdt2, a PCNA-dependent E3 ubiquitin ligase
Havens, C. G., & Walter, J. C. (2011) · Genes & Development · doi:10.1101/gad.2068611 · Cited by 224
“For instance, the E3 ligase CRL2VHL targets HIF1 (hypoxiainducible factor-1) only when its degron motif is hydroxylated, ensuring that HIF1 protein levels increase under hypoxic conditions (Ivan et al. 2001; Jaakkola et al. 2001; Hon et al. 2002; Min et al. 2002).”
BackgroundThe cellular basis for diverse responses to oxygen
Chandel, N. S., & Budinger, G. R. S. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.10.048 · Cited by 219
Kothari, S., Cizeau, J., McMillan-Ward, E., Israels, S. J., Bailes, M., Ens, K., Kirshenbaum, L. A., & Gibson, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206666 · Cited by 218
“…for degradation, but in the absence of oxygen, this degradation is blocked resulting in the translocation of the transcription factor to the nucleus and the activation of target genes (Giatromanolaki and Harris, 2001; Hon et al., 2002; Piret et al., 2002; Sang et al., 2002; Semenza, 2002b).”
BackgroundMcNEILL, L. A., HEWITSON, K. S., CLARIDGE, T. D., SEIBEL, J. F., HORSFALL, L. E., & SCHOFIELD, C. J. (2002) · Biochemical Journal · doi:10.1042/bj20021162 · Cited by 215
Self-citationHIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels
Masson, N., & Ratcliffe, P. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00655 · Cited by 215
Self-citationOxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor
Köditz, J., Nesper, J., Wottawa, M., Stiehl, D. P., Camenisch, G., Franke, C., Myllyharju, J., Wenger, R. H., & Katschinski, D. M. (2007) · Blood · doi:10.1182/blood-2007-06-094441 · Cited by 214
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
Ozer, A., & Bruick, R. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio863 · Cited by 214
“As shown in Figure 3a , modification of these residues is necessary for recognition of the HIF-α subunit by the product of the von Hippel-Lindau gene (pVHL), a component of the E3 ubiquitin ligase complex that targets HIF-α for proteasomal degradatio”
MethodThe von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 214
Maternal Adaptation to High-altitude Pregnancy: An Experiment of Nature—A Review
Moore, L. G., Shriver, M., Bemis, L., Hickler, B., Wilson, M., Brutsaert, T., Parra, E., & Vargas, E. (2004) · Placenta · doi:10.1016/j.placenta.2004.01.008 · Cited by 210
Self-citationMalleable machines take shape in eukaryotic transcriptional regulation
Fuxreiter, M., Tompa, P., Simon, I., Uversky, V. N., Hansen, J. C., & Asturias, F. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.127 · Cited by 209
Searching for the hereditary causes of renal-cell carcinoma
Pavlovich, C. P., & Schmidt, L. S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1364 · Cited by 209
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
Guo, J., Chakraborty, A. A., Liu, P., Gan, W., Zheng, X., Inuzuka, H., Wang, B., Zhang, J., Zhang, L., Yuan, M., et al. (2016) · Science · doi:10.1126/science.aad5755 · Cited by 207
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Zhao, Y., Xing, C., Deng, Y., Ye, C., & Peng, H. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.039 · Cited by 202
Structural regulation of cullin-RING ubiquitin ligase complexes
Duda, D. M., Scott, D. C., Calabrese, M. F., Zimmerman, E. S., Zheng, N., & Schulman, B. A. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.01.003 · Cited by 205
Structural basis for negative regulation of hypoxia-inducible factor-1α by CITED2
Freedman, S. J., Sun, Z.-Y. J., Kung, A. L., France, D. S., Wagner, G., & Eck, M. J. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb936 · Cited by 202
Pugh, C. W., & Ratcliffe, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00103-7 · Cited by 201
Self-citationVan Molle, I., Thomann, A., Buckley, D. L., So, E. C., Lang, S., Crews, C. M., & Ciulli, A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.015 · Cited by 188
Gestational Hypoxia and Developmental Plasticity
Ducsay, C. A., Goyal, R., Pearce, W. J., Wilson, S., Hu, X.-Q., & Zhang, L. (2018) · Physiological Reviews · doi:10.1152/physrev.00043.2017 · Cited by 198
Mitochondria in lung biology and pathology: more than just a powerhouse
Schumacker, P. T., Gillespie, M. N., Nakahira, K., Choi, A. M. K., Crouser, E. D., Piantadosi, C. A., & Bhattacharya, J. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00073.2014 · Cited by 193
Flügel, D., Görlach, A., & Kietzmann, T. (2012) · Blood · doi:10.1182/blood-2011-08-375014 · Cited by 191
Redox regulation of the hypoxia-inducible factor
Pouysségur, J., & Mechta-Grigoriou, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.167 · Cited by 186
“…(VHL) that belongs to an E3-ubiquitin ligase complex and subsequently targets HIF-a for degradation by the proteasome (Kaelin et al., 1999; Maxwell et al., 1999; Ohh, 2000; Hon et al., 2002; Min et al., 2002; Wang et al., 2002; for reviews, see also Kim and Kaelin, 2003; Pugh and Ratcliffe, 2003b).”
BackgroundRegulation of the Hypoxia-Inducible Factor (HIF) by Pro-Inflammatory Cytokines
Malkov, M. I., Lee, C. T., & Taylor, C. T. (2021) · Cells · doi:10.3390/cells10092340 · Cited by 183
The VHL tumor suppressor: master regulator of HIF
Haase, V. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649394 · Cited by 175
Tian, Y.-M., Yeoh, K. K., Lee, M. K., Eriksson, T., Kessler, B. M., Kramer, H. B., Edelmann, M. J., Willam, C., Pugh, C. W., Schofield, C. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211110 · Cited by 182
Self-citationHarnessing the Power of Proteolysis for Targeted Protein Inactivation
Verma, R., Mohl, D., & Deshaies, R. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.010 · Cited by 185
Protein Hydroxylation Catalyzed by 2-Oxoglutarate-dependent Oxygenases
Markolovic, S., Wilkins, S. E., & Schofield, C. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.662627 · Cited by 181
“This modification substantially increases ( 1000-fold) the affinity of HIF- for the von Hippel-Lindau protein (38), which is the substrate-targeting component of an E3 ubiquitin ligase complex, and thus increases signaling for HIF- degradation (39, 40).”
BackgroundSelf-citationpVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
Yang, H., Minamishima, Y. A., Yan, Q., Schlisio, S., Ebert, B. L., Zhang, X., Zhang, L., Kim, W. Y., Olumi, A. F., & Kaelin, W. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.010 · Cited by 179
The ubiquitin system, disease, and drug discovery
Petroski, M. D. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s7 · Cited by 178
Hines, J., Gough, J. D., Corson, T. W., & Crews, C. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217206110 · Cited by 172
Soares, P., Gadd, M. S., Frost, J., Galdeano, C., Ellis, L., Epemolu, O., Rocha, S., Read, K. D., & Ciulli, A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00675 · Cited by 165
Yeo, E.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0233-3 · Cited by 175
E3 ligase ligand chemistries: from building blocks to protein degraders
Sosič, I., Bricelj, A., & Steinebach, C. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00148a · Cited by 163
The von Hippel–Lindau tumor suppressor protein: new insights into oxygen sensing and cancer
Kim, W., & Kaelin, W. G. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00010-2 · Cited by 175
Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
Jochmanova, I., Yang, C., Zhuang, Z., & Pacak, K. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt201 · Cited by 172
Baird, N. A., Turnbull, D. W., & Johnson, E. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608013200 · Cited by 168
Targeting von Hippel-Lindau Pathway in Renal Cell Carcinoma
Patel, P. H., Chadalavada, R. S. V., Chaganti, R. S. K., & Motzer, R. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2254 · Cited by 165
Rabinowitz, M. H. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400386j · Cited by 163
Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors
Chen, L., Endler, A., & Shibasaki, F. (2009) · Experimental and Molecular Medicine · doi:10.3858/emm.2009.41.12.103 · Cited by 164
“Constitutively expressed cytosolic HIF-α subunits are hydroxylated via two prolyl residues comprising Pro402 and Pro564 (Hon et al., 2002) in human HIF-1α, and Pro405 and Pro531 in human HIF-2α (Kondo et al.”
BackgroundThe ubiquitin–proteasome system in cardiovascular diseases—a hypothesis extended
Herrmann, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.033 · Cited by 165
“Proteins that undergo ubiquitin-mediated degradation following phosphorylation or hydroxylation include the inhibitory molecules to nuclear factor kappa B (InB) and hypoxiainducible factor 1 alpha (HIF-1a), respectively [17,18].”
BackgroundYamamoto, J., Ito, T., Yamaguchi, Y., & Handa, H. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00116k · Cited by 158
Milane, L., Duan, Z., & Amiji, M. (2011) · Molecular Pharmaceutics · doi:10.1021/mp1002653 · Cited by 161
Bento, C. F., & Pereira, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2191-8 · Cited by 159
Liao, H., Li, X., Zhao, L., Wang, Y., Wang, X., Wu, Y., Zhou, X., Fu, W., Liu, L., Hu, H.-G., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0171-1 · Cited by 156
Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex
Cardote, T. A. F., Gadd, M. S., & Ciulli, A. (2017) · Structure · doi:10.1016/j.str.2017.04.009 · Cited by 151
“…constituted by pVHL and EloBC (VBC) (Stebbins et al., 1999), VBC in complex with a hypoxia-inducible factor 1a (HIF-1a) peptide (Min et al., 2002; Hon et al., 2002), and the first helical bundle of Cul2 (residues 1–163) bound to VBC (Nguyen et al., 2015), the structure of the whole CRL2VHL…”
BackgroundCellular response to hypoxia involves signaling via Smad proteins
Zhang, H., Akman, H. O., Smith, E. L. P., Zhao, J., Murphy-Ullrich, J. E., & Batuman, O. A. (2003) · Blood · doi:10.1182/blood-2002-02-0629 · Cited by 151
The VHL tumor suppressor and HIF: insights from genetic studies in mice
Kapitsinou, P. P., & Haase, V. H. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402313 · Cited by 151
Targeted therapy for metastatic renal cell carcinoma
Patel, P. H., Chaganti, R. S. K., & Motzer, R. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602978 · Cited by 169
2-Oxoglutarate analogue inhibitors of hif prolyl hydroxylase
Mole, D. R., Schlemminger, I., McNeill, L. A., Hewitson, K. S., Pugh, C. W., Ratcliffe, P. J., & Schofield, C. J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00539-0 · Cited by 145
Self-citationOxygen-Regulated β 2 -Adrenergic Receptor Hydroxylation by EGLN3 and Ubiquitylation by pVHL
Xie, L., Xiao, K., Whalen, E. J., Forrester, M. T., Freeman, R. S., Fong, G., Gygi, S. P., Lefkowitz, R. J., & Stamler, J. S. (2009) · Science Signaling · doi:10.1126/scisignal.2000444 · Cited by 148
Bioorthogonal PROTAC Prodrugs Enabled by On-Target Activation
Chang, M., Gao, F., Pontigon, D., Gnawali, G. R., Xu, H., & Wang, W. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c05159 · Cited by 159
The HIF pathway as a therapeutic target
Hewitson, K. S., & Schofield, C. J. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03202-7 · Cited by 163
Self-citationKuo, M. T. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2095 · Cited by 164
The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination
Jin, J., Wu, Y., Chen, J., Shen, Y., Zhang, L., Zhang, H., Chen, L., Yuan, H., Chen, H., Zhang, W., et al. (2020) · Theranostics · doi:10.7150/thno.46985 · Cited by 144
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Chowdhury, R., Leung, I. K. H., Tian, Y.-M., Abboud, M. I., Ge, W., Domene, C., Cantrelle, F.-X., Landrieu, I., Hardy, A. P., Pugh, C. W., et al. (2016) · Nature Communications · doi:10.1038/ncomms12673 · Cited by 145
Self-citationVadlapatla, R. K., Vadlapudi, A. D., & Mitra, A. K. (2013) · Current Drug Targets · doi:10.2174/13894501113149990015 · Cited by 157
Mészáros, B., Kumar, M., Gibson, T. J., Uyar, B., & Dosztányi, Z. (2017) · Science Signaling · doi:10.1126/scisignal.aak9982 · Cited by 141
Testa, A., Lucas, X., Castro, G. V., Chan, K.-H., Wright, J. E., Runcie, A. C., Gadd, M. S., Harrison, W. T. A., Ko, E.-J., Fletcher, D., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05807 · Cited by 137
Unfavourable consequences of chronic cardiac HIF-1α stabilization
Hölscher, M., Schäfer, K., Krull, S., Farhat, K., Hesse, A., Silter, M., Lin, Y., Pichler, B. J., Thistlethwaite, P., El-Armouche, A., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs014 · Cited by 142
Effect of posttranslational modifications on enzyme function and assembly
Ryšlavá, H., Hýsková, V., Kavan, D., & Vaněk, O. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.03.025 · Cited by 171
Oxygen and Iron Regulation of Iron Regulatory Protein 2
Hanson, E. S., Rawlins, M. L., & Leibold, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302798200 · Cited by 141
Zambelli, B., & Ciurli, S. (2013) · Metal ions in life sciences · doi:10.1007/978-94-007-7500-8_10 · Cited by 173
Collins, I., Wang, H., Caldwell, J. J., & Chopra, R. (2017) · Biochemical Journal · doi:10.1042/bcj20160762 · Cited by 137
Oxygen‐dependent regulation of hypoxia‐inducible factors by prolyl and asparaginyl hydroxylation
Lando, D., Gorman, J. J., Whitelaw, M. L., & Peet, D. J. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03445.x · Cited by 137
Mutations in the VHL gene in sporadic apparently congenital polycythemia
Pastore, Y. D., Jelinek, J., Ang, S., Guan, Y., Liu, E., Jedlickova, K., Krishnamurti, L., & Prchal, J. T. (2003) · Blood · doi:10.1182/blood-2002-06-1843 · Cited by 136
Conditional HIF-1α Expression Produces a Reversible Cardiomyopathy
Bekeredjian, R., Walton, C. B., MacCannell, K. A., Ecker, J., Kruse, F., Outten, J. T., Sutcliffe, D., Gerard, R. D., Bruick, R. K., & Shohet, R. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011693 · Cited by 136
The von Hippel-Lindau gene, kidney cancer, and oxygen sensing.
Kaelin, W. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092803.69761.41 · Cited by 135
“The crystal structure of pVHL bound to HIF reveals that selective binding to hydroxylated HIF is the result of critical hydrogen bonds between the prolyl hydroxyl group and two hydrophilic pVHL residues within the otherwise hydrophobic pVHL domain (84,85).”
BackgroundCowan, A. D., & Ciulli, A. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-104421 · Cited by 130
Ligandability of E3 Ligases for Targeted Protein Degradation Applications
Belcher, B. P., Ward, C. C., & Nomura, D. K. (2023) · Biochemistry · doi:10.1021/acs.biochem.1c00464 · Cited by 132
HIF-1: An Oxygen Response System with Special Relevance to the Kidney
Maxwell, P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092792.97122.e0 · Cited by 132
“A crystal structure of the overall complex of the hydroxylated HIF target peptide with elongin B and elongin C shows that the hydroxyl group fits into a surface pocket, with hydroxylation permitting the formation of two hydrogen bonds (56,57).”
BackgroundSelf-citationMitochondrial regulation of oxygen sensing
Bell, E. L., Emerling, B. M., & Chandel, N. S. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.06.005 · Cited by 130
Koivunen, P., Hirsilä, M., Kivirikko, K. I., & Myllyharju, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604628200 · Cited by 129
Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets
Miyata, T., Takizawa, S., & de Strihou, C. V. Y. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00430.2010 · Cited by 143
Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis
Percy, M. J., Beer, P. A., Campbell, G., Dekker, A. W., Green, A. R., Oscier, D., Rainey, M. G., van Wijk, R., Wood, M., Lappin, T. R. J., et al. (2008) · Blood · doi:10.1182/blood-2008-02-137703 · Cited by 127
Insights towards sulfonamide drug specificity in α-carbonic anhydrases
Aggarwal, M., Kondeti, B., & McKENNA, R. V. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.08.019 · Cited by 128
HIF-1 in Cell Cycle Regulation, Apoptosis, and Tumor Progression
Goda, N., Dozier, S. J., & Johnson, R. S. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603768295212 · Cited by 140
Erythropoiesis‐stimulating agents and other methods to enhance oxygen transport
Elliott, S. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.89 · Cited by 126
Hypoxia and Metabolic Factors That Influence Inflammatory Bowel Disease Pathogenesis
Glover, L. E., & Colgan, S. P. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.056 · Cited by 124
Hypoxia Inducible Factor-1: Its Potential Role In Cerebral Ischemia
Singh, N., Sharma, G., Mishra, V., & Raghubir, R. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9803-9 · Cited by 136
Structural characterization of mammalian bHLH-PAS transcription factors
Wu, D., & Rastinejad, F. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.09.011 · Cited by 122
The Ubiquitin Ligase Siah2 and the Hypoxia Response
Nakayama, K., Qi, J., & Ronai, Z. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0458 · Cited by 122
Prolyl 4‐hydroxylases, master regulators of the hypoxia response
Myllyharju, J. (2013) · Acta Physiologica · doi:10.1111/apha.12096 · Cited by 134
“2; Ivan et al. 2001, Jaakkola et al. 2001, Yu et al. 2001, Hon et al. 2002, Min et al. 2002, Illingworth et al. 2010).”
Osada, R., Horiuchi, A., Kikuchi, N., Yoshida, J., Hayashi, A., Ota, M., Katsuyama, Y., Mellilo, G., & Konishi, I. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.02.010 · Cited by 127
“Because the inactivation of VHL results in increased cellular HIF-1a and HIF-2a expressions [32,33], we also examined the expression of VHL in ovarian carcinomas.”
BackgroundHypoxia signaling in cancer: Implications for therapeutic interventions
Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023) · MedComm · doi:10.1002/mco2.203 · Cited by 119
PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
Kelm, J. M., Pandey, D. S., Malin, E., Kansou, H., Arora, S., Kumar, R., & Gavande, N. S. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01707-5 · Cited by 110
Update on carbonic anhydrase inhibitors: a patent review (2008 – 2011)
Aggarwal, M., & McKENNA, R. V. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.707646 · Cited by 113
Nangaku, M., Izuhara, Y., Takizawa, S., Yamashita, T., Fujii-Kuriyama, Y., Ohneda, O., Yamamoto, M., van Ypersele de Strihou, C., Hirayama, N., & Miyata, T. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.148551 · Cited by 110
Fan, L., Li, J., Yu, Z., Dang, X., & Wang, K. (2014) · BioMed Research International · doi:10.1155/2014/239356 · Cited by 119
TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains
Kaiho-Soma, A., Akizuki, Y., Igarashi, K., Endo, A., Shoda, T., Kawase, Y., Demizu, Y., Naito, M., Saeki, Y., Tanaka, K., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.023 · Cited by 109
The effect of erythropoietin on normal and neoplastic cells
Sinclair, A. M., & Elliott (2012) · Biologics · doi:10.2147/btt.s32281 · Cited by 136
Metadata
- Authors
- Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Jones, E. Yvonne
- ORCID
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6892
- Pages
- 975-978
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2167786713
- Cited by
- 751
- References
- 31
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 37 · 2021: 35 · 2020: 43 · 2019: 19 · 2018: 24 · 2017: 23 · 2016: 28 · 2015: 24 · 2014: 20 · 2013: 23 · 2012: 26
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, von Hippel-Lindau protein, E3 ubiquitin ligase, hypoxia, oxygen sensing, protein-protein binding, crystal structure, hydrogen bonding, ubiquitination, proteasomal degradation, transcriptional regulation
- MeSH terms
- Elongin, Amino Acid Sequence, Hypoxia, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Kinetics, Ligases, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Structure-Activity Relationship, Substrate Specificity, Transcription Factors, Sequence Alignment, Crystallography, X-Ray, Surface Plasmon Resonance, Amino Acid Motifs, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.